Solomon, D. H., Giles, J. T., Liao, K. P., Ridker, P. M., Rist, P. M., Glynn, R. J., Broderick, R., Lu, F., Murray, M. T., Vanni, K., Santacroce, L. M., Abohashem, S., Robson, P. M., Fayad, Z., Mani, V., Tawakol, A., & Bathon, J. (2022). Reducing cardiovascular risk with immunomodulators: a randomised active comparator trial among patients with rheumatoid arthritis. Annals of the Rheumatic Diseases, 82(3), 324–330. https://doi.org/10.1136/ard-2022-223302
Subjects:
Rheumatoid Arthritis
(OpenAlex Topic)
Hemophagocytic Lymphohistiocytosis and Related Disorders
(OpenAlex Topic)
Systemic Lupus Erythematosus and Antiphospholipid Syndrome
(OpenAlex Topic)
Antirheumatic Agents
(MeSH)
Cardiovascular Diseases
(MeSH)
Arthritis, Rheumatoid
(MeSH)
Arteritis
(MeSH)
Publication Type:
Article
Unique ID:
10.1136/ard-2022-223302
PMID:
Journal:
Publication Date:
Data Source:
PubMed